X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Panacea Biotech with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs WYETH LTD - Comparison Results

PANACEA BIOTECH    Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH WYETH LTD PANACEA BIOTECH/
WYETH LTD
 
P/E (TTM) x 81.4 27.7 293.7% View Chart
P/BV x 1.8 5.3 33.8% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 PANACEA BIOTECH   WYETH LTD
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-14
WYETH LTD
Mar-13
PANACEA BIOTECH/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs1491,044 14.2%   
Low Rs82818 10.1%   
Sales per share (Unadj.) Rs84.1298.6 28.2%  
Earnings per share (Unadj.) Rs-18.357.2 -32.0%  
Cash flow per share (Unadj.) Rs-6.758.4 -11.5%  
Dividends per share (Unadj.) Rs017.00 0.0%  
Dividend yield (eoy) %01.8 0.0%  
Book value per share (Unadj.) Rs83.7249.5 33.6%  
Shares outstanding (eoy) m61.2522.72 269.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.43.1 44.0%   
Avg P/E ratio x-6.316.3 -38.8%  
P/CF ratio (eoy) x-17.215.9 -108.2%  
Price / Book Value ratio x1.43.7 37.0%  
Dividend payout %029.7 0.0%   
Avg Mkt Cap Rs m7,07421,157 33.4%   
No. of employees `0002.80.5 558.9%   
Total wages/salary Rs m1,449400 362.3%   
Avg. sales/employee Rs Th1,874.113,787.4 13.6%   
Avg. wages/employee Rs Th527.0813.0 64.8%   
Avg. net profit/employee Rs Th-407.72,643.3 -15.4%   
INCOME DATA
Net Sales Rs m5,1546,783 76.0%  
Other income Rs m100353 28.3%   
Total revenues Rs m5,2547,136 73.6%   
Gross profit Rs m-7661,617 -47.4%  
Depreciation Rs m71127 2,672.9%   
Interest Rs m1,5036 27,327.3%   
Profit before tax Rs m-2,8811,938 -148.6%   
Minority Interest Rs m110-   
Prior Period Items Rs m-60-   
Extraordinary Inc (Exp) Rs m1,771-5 -34,723.5%   
Tax Rs m17632 2.7%   
Profit after tax Rs m-1,1211,301 -86.2%  
Gross profit margin %-14.923.8 -62.4%  
Effective tax rate %-0.632.6 -1.8%   
Net profit margin %-21.819.2 -113.5%  
BALANCE SHEET DATA
Current assets Rs m3,8106,984 54.6%   
Current liabilities Rs m8,3652,056 406.9%   
Net working cap to sales %-88.472.6 -121.7%  
Current ratio x0.53.4 13.4%  
Inventory Days Days15699 156.8%  
Debtors Days Days6724 280.8%  
Net fixed assets Rs m14,480244 5,927.2%   
Share capital Rs m61227 27.0%   
"Free" reserves Rs m9035,441 16.6%   
Net worth Rs m5,1275,668 90.5%   
Long term debt Rs m5,83225 23,326.8%   
Total assets Rs m19,4337,901 246.0%  
Interest coverage x-0.9353.3 -0.3%   
Debt to equity ratio x1.10 25,787.2%  
Sales to assets ratio x0.30.9 30.9%   
Return on assets %2.016.5 11.9%  
Return on equity %-21.922.9 -95.3%  
Return on capital %3.634.0 10.7%  
Exports to sales %24.50.2 11,239.4%   
Imports to sales %10.236.3 28.0%   
Exports (fob) Rs m1,26415 8,539.2%   
Imports (cif) Rs m5252,465 21.3%   
Fx inflow Rs m1,53915 10,126.3%   
Fx outflow Rs m9422,677 35.2%   
Net fx Rs m597-2,662 -22.4%   
CASH FLOW
From Operations Rs m599923 64.9%  
From Investments Rs m-438317 -138.2%  
From Financial Activity Rs m-303-481 62.9%  
Net Cashflow Rs m-141759 -18.6%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 0.6 11.3 5.3%  
FIIs % 1.3 7.2 18.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 30.4 77.6%  
Shareholders   10,259 21,978 46.7%  
Pledged promoter(s) holding % 35.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   UNICHEM LAB  VENUS REMEDIES  IPCA LABS  WOCKHARDT LTD.  AUROBINDO PHARMA  

Compare PANACEA BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Aug 21, 2017 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 5-YR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS